Selected research
Industry Research
Pharmaceutical Grade Croscarmellose Sodium Industry Research Report 2026
Market perspective
The global Pharmaceutical Grade Croscarmellose Sodium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Grade Croscarmellose Sodium is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Grade Croscarmellose Sodium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade Croscarmellose Sodium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Grade Croscarmellose Sodium include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Grade Croscarmellose Sodium market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Pharmaceutical Grade Croscarmellose Sodium.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Grade Croscarmellose Sodium Market by Company
Roquette
JRS Pharma
DFE Pharma
Mingtai Chemical
Nichirin Chemical Industries
Patel Chem Specialities
NB Entrepreneurs
Nitika Pharmaceutical Specialities
Anhui Sunhere Pharmaceutical Excipients
Jiangxi Alpha Hi-tech Pharmaceutical
Shandong Yulong Cellulose Technology
Pharmaceutical Grade Croscarmellose Sodium Segment by Type
Powder
Particles
Pharmaceutical Grade Croscarmellose Sodium Segment by Application
Tablets
Capsules
Granules
Pharmaceutical Grade Croscarmellose Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Croscarmellose Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Croscarmellose Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Croscarmellose Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Grade Croscarmellose Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Grade Croscarmellose Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Grade Croscarmellose Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Particles
Applications
- Tablets
- Capsules
- Granules
Companies covered
- Roquette
- JRS Pharma
- DFE Pharma
- Mingtai Chemical
- Nichirin Chemical Industries
- Patel Chem Specialities
- NB Entrepreneurs
- Nitika Pharmaceutical Specialities
- Anhui Sunhere Pharmaceutical Excipients
- Jiangxi Alpha Hi-tech Pharmaceutical
- Shandong Yulong Cellulose Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Grade Croscarmellose Sodium by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Powder
- 2.2.3 Particles
- 2.3 Pharmaceutical Grade Croscarmellose Sodium by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Capsules
- 2.3.4 Granules
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Pharmaceutical Grade Croscarmellose Sodium Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Pharmaceutical Grade Croscarmellose Sodium Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Pharmaceutical Grade Croscarmellose Sodium Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Grade Croscarmellose Sodium Production by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Value by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Grade Croscarmellose Sodium Average Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Grade Croscarmellose Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Grade Croscarmellose Sodium Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Grade Croscarmellose Sodium Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Grade Croscarmellose Sodium Manufacturers Established Date
- 3.8 Global Pharmaceutical Grade Croscarmellose Sodium Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roquette
- 4.1.1 Roquette Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.1.2 Roquette Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.1.3 Roquette Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Roquette Product Portfolio
- 4.1.5 Roquette Recent Developments
- 4.2 JRS Pharma
- 4.2.1 JRS Pharma Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.2.2 JRS Pharma Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.2.3 JRS Pharma Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 JRS Pharma Product Portfolio
- 4.2.5 JRS Pharma Recent Developments
- 4.3 DFE Pharma
- 4.3.1 DFE Pharma Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.3.2 DFE Pharma Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.3.3 DFE Pharma Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 DFE Pharma Product Portfolio
- 4.3.5 DFE Pharma Recent Developments
- 4.4 Mingtai Chemical
- 4.4.1 Mingtai Chemical Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.4.2 Mingtai Chemical Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.4.3 Mingtai Chemical Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Mingtai Chemical Product Portfolio
- 4.4.5 Mingtai Chemical Recent Developments
- 4.5 Nichirin Chemical Industries
- 4.5.1 Nichirin Chemical Industries Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.5.2 Nichirin Chemical Industries Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.5.3 Nichirin Chemical Industries Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Nichirin Chemical Industries Product Portfolio
- 4.5.5 Nichirin Chemical Industries Recent Developments
- 4.6 Patel Chem Specialities
- 4.6.1 Patel Chem Specialities Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.6.2 Patel Chem Specialities Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.6.3 Patel Chem Specialities Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Patel Chem Specialities Product Portfolio
- 4.6.5 Patel Chem Specialities Recent Developments
- 4.7 NB Entrepreneurs
- 4.7.1 NB Entrepreneurs Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.7.2 NB Entrepreneurs Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.7.3 NB Entrepreneurs Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 NB Entrepreneurs Product Portfolio
- 4.7.5 NB Entrepreneurs Recent Developments
- 4.8 Nitika Pharmaceutical Specialities
- 4.8.1 Nitika Pharmaceutical Specialities Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.8.2 Nitika Pharmaceutical Specialities Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.8.3 Nitika Pharmaceutical Specialities Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Nitika Pharmaceutical Specialities Product Portfolio
- 4.8.5 Nitika Pharmaceutical Specialities Recent Developments
- 4.9 Anhui Sunhere Pharmaceutical Excipients
- 4.9.1 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.9.2 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.9.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Anhui Sunhere Pharmaceutical Excipients Product Portfolio
- 4.9.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments
- 4.10 Jiangxi Alpha Hi-tech Pharmaceutical
- 4.10.1 Jiangxi Alpha Hi-tech Pharmaceutical Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.10.2 Jiangxi Alpha Hi-tech Pharmaceutical Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.10.3 Jiangxi Alpha Hi-tech Pharmaceutical Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Jiangxi Alpha Hi-tech Pharmaceutical Product Portfolio
- 4.10.5 Jiangxi Alpha Hi-tech Pharmaceutical Recent Developments
- 4.11 Shandong Yulong Cellulose Technology
- 4.11.1 Shandong Yulong Cellulose Technology Pharmaceutical Grade Croscarmellose Sodium Company Information
- 4.11.2 Shandong Yulong Cellulose Technology Pharmaceutical Grade Croscarmellose Sodium Business Overview
- 4.11.3 Shandong Yulong Cellulose Technology Pharmaceutical Grade Croscarmellose Sodium Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Shandong Yulong Cellulose Technology Product Portfolio
- 4.11.5 Shandong Yulong Cellulose Technology Recent Developments
5 Global Pharmaceutical Grade Croscarmellose Sodium Production by Region
- 5.1 Global Pharmaceutical Grade Croscarmellose Sodium Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Grade Croscarmellose Sodium Production by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Grade Croscarmellose Sodium Production by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Forecast by Region (2027-2032)
- 5.3 Global Pharmaceutical Grade Croscarmellose Sodium Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Pharmaceutical Grade Croscarmellose Sodium Production Value by Region: 2021-2032
- 5.4.1 Global Pharmaceutical Grade Croscarmellose Sodium Production Value by Region: 2021-2026
- 5.4.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Value Forecast by Region (2027-2032)
- 5.5 Global Pharmaceutical Grade Croscarmellose Sodium Market Price Analysis by Region (2021-2026)
- 5.6 Global Pharmaceutical Grade Croscarmellose Sodium Production and Value, YOY Growth
- 5.6.1 North America Pharmaceutical Grade Croscarmellose Sodium Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Pharmaceutical Grade Croscarmellose Sodium Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Pharmaceutical Grade Croscarmellose Sodium Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Pharmaceutical Grade Croscarmellose Sodium Production Value Estimates and Forecasts (2021-2032)
6 Global Pharmaceutical Grade Croscarmellose Sodium Consumption by Region
- 6.1 Global Pharmaceutical Grade Croscarmellose Sodium Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Grade Croscarmellose Sodium Consumption by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Grade Croscarmellose Sodium Consumption by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Grade Croscarmellose Sodium Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Grade Croscarmellose Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Grade Croscarmellose Sodium Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Grade Croscarmellose Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Grade Croscarmellose Sodium Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Grade Croscarmellose Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Grade Croscarmellose Sodium Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Pharmaceutical Grade Croscarmellose Sodium Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Pharmaceutical Grade Croscarmellose Sodium Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Pharmaceutical Grade Croscarmellose Sodium Production by Type (2021-2032)
- 7.1.1 Global Pharmaceutical Grade Croscarmellose Sodium Production by Type (2021-2032) & (t)
- 7.1.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Market Share by Type (2021-2032)
- 7.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Value by Type (2021-2032)
- 7.2.1 Global Pharmaceutical Grade Croscarmellose Sodium Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Value Market Share by Type (2021-2032)
- 7.3 Global Pharmaceutical Grade Croscarmellose Sodium Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Pharmaceutical Grade Croscarmellose Sodium Production by Application (2021-2032)
- 8.1.1 Global Pharmaceutical Grade Croscarmellose Sodium Production by Application (2021-2032) & (t)
- 8.1.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Market Share by Application (2021-2032)
- 8.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Value by Application (2021-2032)
- 8.2.1 Global Pharmaceutical Grade Croscarmellose Sodium Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Pharmaceutical Grade Croscarmellose Sodium Production Value Market Share by Application (2021-2032)
- 8.3 Global Pharmaceutical Grade Croscarmellose Sodium Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Pharmaceutical Grade Croscarmellose Sodium Value Chain Analysis
- 9.1.1 Pharmaceutical Grade Croscarmellose Sodium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Pharmaceutical Grade Croscarmellose Sodium Production Mode & Process
- 9.2 Pharmaceutical Grade Croscarmellose Sodium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Grade Croscarmellose Sodium Distributors
- 9.2.3 Pharmaceutical Grade Croscarmellose Sodium Customers
10 Global Pharmaceutical Grade Croscarmellose Sodium Analyzing Market Dynamics
- 10.1 Pharmaceutical Grade Croscarmellose Sodium Industry Trends
- 10.2 Pharmaceutical Grade Croscarmellose Sodium Industry Drivers
- 10.3 Pharmaceutical Grade Croscarmellose Sodium Industry Opportunities and Challenges
- 10.4 Pharmaceutical Grade Croscarmellose Sodium Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst